Biological Dynamics’ Senior Scientist, Jean Lewis, PhD will be presenting her work on using Biological Dynamic technology to screen whole blood and plasma samples from pancreatic cancer patients for the presence of both the exosome-associated protein CD63 and glypican-1 (GPC-1).
Dr. Lewis was a part of completcross-disciplinary team of scientists from the UC San Diego Jacobs School of Engineering and clinicians at Moores Cancer Center. The collaboration is led by Dr. Heller, Professor Emeritus of Nanoengineering at the UC San Diego Jacobs School of Engineering, who is now at OHSU Knight Cancer Institute.
Session: Novel Technology Accelerating Early Detection
Thursday, Oct 4, 2018, 9:25 AM -12:00PM PDT